Search Results
233 results
Your search is now limited to «Rheumatoid Arthritis» expert search.
MedicineNet 04/21/2019 00:51
Factors that contribute to a higher risk of kidney disease in rheumatoid arthritis patients include more severe inflammation in the first year of rheumatoid arthritis, use of corticosteroids, high blood pressure, obesity and high cholesterol levels.
More from MedicineNet:
Medindia.com 04/20/2019 14:12
They found that bioelectronic medicine treatment was effective in inhibiting the production of cytokines, proteins that mediate inflammation and reduce the inflammatory responses in patients with rheumatoid arthritis.
More from Medindia.com:
DoctorsLounge 04/19/2019 20:00
CVE rates are reducing in this population: this requires further investigation and does not support a primary prevention strategy involving statin use in all rheumatoid arthritis patients," the authors write.
More from DoctorsLounge:
Hi Arferitis, sorry to read about your diagnosis. I have psoriatic arthritis (had it since my 20s) and my rheumatologist told me that biological treatments for the arthritis were now a no go for me due to having cancer. I am back on sulphasalasine as I don’t really want to do anything that is contraindicated. I know that this drug also lowers m6 mood unevsystem but I’m trying to strike a balance. I was on methotrexate for years and was offered biological as I qualified for them but I decided not to go there. I tested positive for latent TB when I was being offered the biological therapy and so ended up on a six month treatment for that. Can you try going back to another drug to see how that works out? Best wishes,
More from Macmillan Cancer - Prostate Forum:
CreakyJoints 04/19/2019 07:30
With an inflammatory autoimmune disease like rheumatoid arthritis, your immune system is switched on, but is attacking your body’s own tissues rather than a foreign invader like a virus or bacteria.
More from CreakyJoints:
WN.com 04/19/2019 01:50
Patients with rheumatoid arthritis have an approximately 50 per cent higher risk of experiencing cardiovascular events such as heart attack and stroke compared with the general population.
More from WN.com:
PubMed News (NIH) 04/18/2019
Contributors : Tao Yue ; Lianbo Xiao Series Type : Expression profiling by high throughput sequencing Organism : Homo sapiens. This study aimed to investigate the effect of lnc-ITSN1-2 on cell proliferation, apoptosis and inflammation as well as its possible regulatory network and molecular mechanisms in rheumatoid arthritis (RA).
More from PubMed News (NIH):
Arthritis Research & Therapy 04/17/2019 20:00
Lower vaccine responses in RA populations are generally expected, depending on RA disease control, as compared to the healthy adults [ 31.
More from Arthritis Research & Therapy:
To compare the survival rates of RA patients in MTX- and MTX+ETA/INF-treated groups, the piecewise constant baseline hazard model was fitted.
More from International Journal of COPD:
Healio News 04/17/2019 16:15
... that uses vibration to stimulate the cymba concha on the external ear can inhibit the production of TNF, IL-1 beta, and IL-6 in healthy individuals, as well as improve symptoms in patients with rheumatoid arthritis, according to data published in Bioelectronic Medicine.
More from Healio News:
Human medicines European public assessment report (EPAR): Idacio, adalimumab, Arthritis, Rheumatoid,Arthritis, Juvenile Rheumatoid,Psoriasis,Arthritis, Psoriatic,Spondylitis, Ankylosing,Uveitis,Hidradenitis Suppurativa,Colitis, Ulcerative,Crohn Disease, Date of authorisation: 02/04/2019, Status: Authorised.
More from European Medicines Agency - EMEA (EU):
ClinicalTrials.gov 04/16/2019 08:26
Condition : Rheumatoid Arthritis Interventions : Drug: Baricitinib; Drug: TNF Inhibitor Sponsors : Eli Lilly and Company; Incyte Corporation Not yet recruiting.
More from ClinicalTrials.gov:
News-Medical.net 04/12/2019 02:32
Biomolecular researcher provides comprehensive profile of B cells in rheumatoid arthritis.
More from News-Medical.net:
Clinical Studies in Rheumatoid Arthritis The Companys proposed RA studies were discussed with the FDA during an in-person meeting, and through follow-up collaborative efforts.
More from Global Banking & Finance Review (UK):

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors

Cells

Diagnostics and Therapeutics

Diseases

Drugs - Brand Names

Drugs - Generic

Enzymes

Genes

Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices

Proteins

Sources

Strategic Scenarios

Trends

Hints:

On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 


  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications